Oral Abstract Session:
88. Staph aureus: Screening and Prevention
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 157ABC

Learning Objectives:

none

Target Audience: other, Academicians

Topical Category: N. Hospital-acquired and surgical infections, infection control, and health outcomes including general public health and health services research

Tracks: Adult ID, Pediatric ID

Moderators:  Frank Lowy, MD, Columbia University and Daniel J. Diekema, University of Iowa Health Care

Presentations:

3:00 PM
772
One-Year Risk of Methicillin Resistant Staphylococcus aureus Infection Following 211,339 MRSA Screening Tests
Jessica Ridgway, MD ; Courtney Hebert, MD ; Lance Peterson, MD ; Ari Robicsek, MD

3:15 PM
773
Prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE), and Clostridium difficile Infection (CDI) in Canadian Hospitals
Andrew Simor, MD, FRCPC, FIDSA ; Victoria Williams, BSc, BASc, CIC ; Oscar E. Larios, MD ; Karl Weiss, MD ; Felicia Laing, BSc, MSc ; Zahir Hirji, MSc ; Denise Gravel, BScN, MSc ; Allison McGeer, MD

3:30 PM
774
The Effect of a Methicillin-Resistant Staphylococcus aureus Bundle on the Incidence of Hospital-Acquired Infections with Clostridium difficile, Vancomycin-Resistant Enterococcus and MRSA
David Saunders, MD ; Emilio Perez-Jorge, MD ; Ronald Markert, PhD ; Patti Hoffman, RN, MPH ; Vanessa Christian, RN, MS ; Laila Fernandes, MD ; Jack Bernstein, MD

4:00 PM
776
Methicillin-Resistant Staphylococcus aureus screening and isolation: is this an effective infection control strategy?
Sarla Patil, MD ; Thomas Huber, Ph.D ; Zehra Hussain, B.S. ; Laurel Copeland, PhD ; Chetan Jinadatha, MD, MPH

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

F. Lowy, cubist: Grant Investigator, Grant recipient
pfizer: Grant Investigator, Grant recipient

D. J. Diekema, Merck: Grant Investigator, Research grant

F. Lowy, cubist: Grant Investigator, Grant recipient
pfizer: Grant Investigator, Grant recipient

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.